April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Visual and surgical midterm outcome of minimally invasive pars plana vitrectomy for diabetic retinopathy
Author Affiliations & Notes
  • Shulamit Schwartz
    Ophthalmology, Denver Health Medical Center, Denver, CO
    opthalmology, Tel Aviv Medical Center, Tel Aviv, Israel
  • Ramanath Bhandari
    Ophthalmology, Denver Health Medical Center, Denver, CO
    ophthalmology, Rocky Mountain Lion Eye institute, University of colorado, aurora, CO
  • Adiel Barak
    opthalmology, Tel Aviv Medical Center, Tel Aviv, Israel
  • Naresh Mandava
    ophthalmology, Rocky Mountain Lion Eye institute, University of colorado, aurora, CO
  • Anat Loewenstein
    opthalmology, Tel Aviv Medical Center, Tel Aviv, Israel
  • Hugo Quiroz-Mercado
    Ophthalmology, Denver Health Medical Center, Denver, CO
    ophthalmology, Rocky Mountain Lion Eye institute, University of colorado, aurora, CO
  • Footnotes
    Commercial Relationships Shulamit Schwartz, None; Ramanath Bhandari, None; Adiel Barak, None; Naresh Mandava, None; Anat Loewenstein, None; Hugo Quiroz-Mercado, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2303. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shulamit Schwartz, Ramanath Bhandari, Adiel Barak, Naresh Mandava, Anat Loewenstein, Hugo Quiroz-Mercado; Visual and surgical midterm outcome of minimally invasive pars plana vitrectomy for diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2303. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the visual outcome and complications rate of minimally invasive pars plana vitrectomy (PPV) in diabetic patients with complications of proliferative diabetic retinopathy (PDR).

Methods: Retrospective, interventional, consecutive case series. 117 patients who underwent 144 small gauge (23 or 25) PPV for PDR were included. Main indications were none clearing vitreous hemorrhage (NCVH) in 78 eyes, tractional retinal detachment (TRD) in 33 eyes and macular pathologies in 18 eyes. 36% had a combined vitrectomy and cataract extraction. Primary outcome was change in visual acuity (VA) 3 and 6 six months after operation. Secondary outcomes were complications rate and risk factors.

Results: Mean age was 54.5±10.2 years. Mean diabetes duration was 12.3±8 years. 21.4% had Type I diabetes, 63.4% of all patients were treated with Insulin and 32.5% required dialysis perioperatively. Mean HbA1c was 8.4% ±1.9. 29.1% of patients had more than one vitrectomy overall. Mean pre-operative VA was 1.62 logMAR. 81.9% of eyes were legally blind at the time of operation with 6 showing light perception (LP), 25 detecting hand movements (HM), and 54 counting fingers (CF). At 3 and 6 months post-operative visits, mean VA improved to 1.2 and 1.13 logMAR respectively (p<0.0001). At 6 months only 55 eyes (38.2%) had poor VA of 1.0 logMAR or less, with 2 with no LP, 3 showing LP, 12 detecting HM, and 13 CF. In all, 63.6% of eyes with TRD and 68.4% with NCVH achieved a better VA than 1.0 logMAR at 6 months. VA was preserved in 43 patients between visits. Hispanic race (p=0.018), Insulin treatment(p=0.042), prior cataract extraction(p=0.003), internal limiting membrane peeling (p=0.001) and operation length (p=0.0005) were found to be significant risk factors for less favorable VA at 3 and/or 6 months. Complications included NCVH (12.5%), TRD (4.9%), macular edema (4.9%), rubeosis (4.2%), neovascular glaucoma (2.8%),optic atrophy (4.2%), hypotony and phthisis (0.007%). Transient VH, ocular hypertension and hyphema occurred in 15.3%, 12.5% and 3.5% of eyes respectively. 23.1% of phakic eyes developed visually significant cataract. 11.8% required another vitrectomy for either NCVH or TRD.

Conclusions: Diabetic patients can observe improvement in VA with a low complications rate after minimally invasive PPV for PDR, which is maintained during mid-term follow-up.

Keywords: 688 retina • 499 diabetic retinopathy • 700 retinal neovascularization  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×